BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34220381)

  • 21. Diagnostic accuracy of
    Kim SJ; Lee SW; Pak K; Kim IJ; Kim K
    Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake: a systematic review and meta-analysis.
    Son GM; Kim SJ
    Abdom Radiol (NY); 2019 Feb; 44(2):456-463. PubMed ID: 30132094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
    Kim K; Kim SJ
    Clin Imaging; 2021 Nov; 79():251-258. PubMed ID: 34157501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of
    Zhang Q; Xi Y; Li D; Yuan Z; Dong J
    J Orthop Surg Res; 2020 Jun; 15(1):229. PubMed ID: 32571371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of
    Ko WS; Kim SJ
    Hell J Nucl Med; 2023; 26(2):132-139. PubMed ID: 37527049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can
    Du B; Wang S; Cui Y; Liu G; Li X; Li Y
    BMJ Open; 2021 Jun; 11(6):e044313. PubMed ID: 34103313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis.
    Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J
    Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the Diagnostic Accuracies of F-18 Fluorodeoxyglucose Positron Emission Tomography and Magnetic Resonance Imaging for the Detection of Spondylodiscitis: A Meta-analysis.
    Kim SJ; Pak K; Kim K; Lee JS
    Spine (Phila Pa 1976); 2019 Apr; 44(7):E414-E422. PubMed ID: 30889146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis.
    Seol HY; Kim YS; Kim SJ
    Thorac Cancer; 2020 Nov; 11(11):3260-3268. PubMed ID: 32951338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
    Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of
    Treglia G; Pascale M; Lazzeri E; van der Bruggen W; Delgado Bolton RC; Glaudemans AWJM
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1287-1301. PubMed ID: 31729539
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
    Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
    Yin Y; Liu X; Yang X; Guo J; Wang Q; Chen L
    Spine J; 2018 Dec; 18(12):2323-2332. PubMed ID: 30121323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis.
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Nievelstein RA
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):565-74. PubMed ID: 24281821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.